Loading...

Janus Henderson Global Life Sciences Fund

JAGLX•NASDAQ
Financial Services
Asset Management - Global
$68.04
$-0.47(-0.69%)

Janus Henderson Global Life Sciences Fund (JAGLX) Stock Overview

Explore Janus Henderson Global Life Sciences Fund’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 71.9/100

Key Financials

Market Cap4.3B
P/E RatioN/A
EPS (TTM)N/A
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Week$66.10
1 Month$66.99
3 Months$69.84
1 Year Target$78.30

JAGLX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Janus Henderson Global Life Sciences Fund (JAGLX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 70.03, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $78.30.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 4.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.55%
5-Day Change
2.09%
1-Month Change
-7.07%
3-Month Change
-6.88%
6-Month Change
-18.96%
Year-to-Date (YTD) Change
-5.46%
1-Year Change
-10.55%
3-Year Change
-3.91%
5-Year Change
15.95%
All-Time (Max) Change
541.10%

Contact Information

303-333-3863
151 Detroit Street, Denver, CO, 80206

Company Facts

IPO DateDec 31, 1998
CountryUS
Actively Trading

Frequently Asked Questions

;